Zweytick D - Search Results

1

Extended ultrastructural characterization of chordoma cells: the link to new therapeutic options.

Kolb D, Pritz E, Steinecker-Frohnwieser B, Lohberger B, Deutsch A, Kroneis T, El-Heliebi A, Dohr G, Meditz K, Wagner K, Koefeler H, Leitinger G, Leithner A, Liegl-Atzwanger B, Zweytick D, Rinner B. Kolb D, et al. Among authors: zweytick d. PLoS One. 2014 Dec 5;9(12):e114251. doi: 10.1371/journal.pone.0114251. eCollection 2014. PLoS One. 2014. PMID: 25479055 Free PMC article.

2

In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy.

Riedl S, Rinner B, Asslaber M, Schaider H, Walzer S, Novak A, Lohner K, Zweytick D. Riedl S, et al. Among authors: zweytick d. Biochim Biophys Acta. 2011 Nov;1808(11):2638-45. doi: 10.1016/j.bbamem.2011.07.026. Epub 2011 Jul 26. Biochim Biophys Acta. 2011. PMID: 21810406 Free PMC article.

3

Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.

Riedl S, Rinner B, Schaider H, Lohner K, Zweytick D. Riedl S, et al. Among authors: zweytick d. Biometals. 2014 Oct;27(5):981-97. doi: 10.1007/s10534-014-9749-0. Epub 2014 May 18. Biometals. 2014. PMID: 24838743 Free PMC article.

4

Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.

Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D. Riedl S, et al. Among authors: zweytick d. Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31. doi: 10.1016/j.bbamem.2015.07.018. Epub 2015 Aug 1. Biochim Biophys Acta. 2015. PMID: 26239537 Free article.

5

MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.

Rinner B, Gandolfi G, Meditz K, Frisch MT, Wagner K, Ciarrocchi A, Torricelli F, Koivuniemi R, Niklander J, Liegl-Atzwanger B, Lohberger B, Heitzer E, Ghaffari-Tabrizi-Wizsy N, Zweytick D, Zalaudek I. Rinner B, et al. Among authors: zweytick d. Sci Rep. 2017 May 18;7(1):2098. doi: 10.1038/s41598-017-02197-y. Sci Rep. 2017. PMID: 28522871 Free PMC article.

6

In vitro and in vivo cytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanoma.

Riedl S, Rinner B, Schaider H, Liegl-Atzwanger B, Meditz K, Preishuber-Pflügl J, Grissenberger S, Lohner K, Zweytick D. Riedl S, et al. Among authors: zweytick d. Oncotarget. 2017 May 11;8(42):71817-71832. doi: 10.18632/oncotarget.17823. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069749 Free PMC article.

7

Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.

Wodlej C, Riedl S, Rinner B, Leber R, Drechsler C, Voelker DR, Choi JY, Lohner K, Zweytick D. Wodlej C, et al. Among authors: zweytick d. PLoS One. 2019 Jan 25;14(1):e0211187. doi: 10.1371/journal.pone.0211187. eCollection 2019. PLoS One. 2019. PMID: 30682171 Free PMC article.

8

Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization.

Heitzer E, Groenewoud A, Meditz K, Lohberger B, Liegl-Atzwanger B, Prokesch A, Kashofer K, Behrens D, Haybaeck J, Kolb-Lenz D, Koefeler H, Riedl S, Schaider H, Fischer C, Snaar-Jagalska BE, de'Jong D, Szuhai K, Zweytick D, Rinner B. Heitzer E, et al. Among authors: zweytick d. Sci Rep. 2019 Mar 11;9(1):4096. doi: 10.1038/s41598-019-40570-1. Sci Rep. 2019. PMID: 30858407 Free PMC article.

9

Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.

Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D. Grissenberger S, et al. Among authors: zweytick d. Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183264. doi: 10.1016/j.bbamem.2020.183264. Epub 2020 Mar 7. Biochim Biophys Acta Biomembr. 2020. PMID: 32151609 Free article.

10

Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.

Maxian T, Gerlitz L, Riedl S, Rinner B, Zweytick D. Maxian T, et al. Among authors: zweytick d. Int J Mol Sci. 2021 Aug 6;22(16):8469. doi: 10.3390/ijms22168469. Int J Mol Sci. 2021. PMID: 34445175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page